Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 17, 2010 - Issue 2
204
Views
0
CrossRef citations to date
0
Altmetric
Erratum

Erratum

This article refers to:
ALκI (UNK) – primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review

ALκI (UNK) – primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review, Amyloid, March 2010; 17(1): 10–23.

An error in the print version of this article has been brought to our attention by the authors. and should have been printed in colour instead of grayscale. The corrected figures appear below in colour.

The publishers would like to apologize to the authors and readers for any inconvenience caused.

Figure 1.  Perivascular plasma cells (arrows) surrounded by amyloid deposits. Stain: Immunohistochemistry using anti-ALκ (KRA) as primary antibody and 3-amino-9-ethylcarbazole (AEC) as chromogene (ALκ and κ-chains in serum and plasmacells are stained red), counterstain with haematoxylin (blue).

Figure 1.  Perivascular plasma cells (arrows) surrounded by amyloid deposits. Stain: Immunohistochemistry using anti-ALκ (KRA) as primary antibody and 3-amino-9-ethylcarbazole (AEC) as chromogene (ALκ and κ-chains in serum and plasmacells are stained red), counterstain with haematoxylin (blue).

Figure 2.  Immunohistochemical identification of the amyloid of patient UNK using different antibodies. (a), anti-κBJP (mix); (b), anti-ALκ (SIN); (c), anti-ALκ (KRA); (d), anti-ALλ (HEN). Amyloid deposits are shown by the diagonal arrows; blood is indicated by the vertical arrows.

Figure 2.  Immunohistochemical identification of the amyloid of patient UNK using different antibodies. (a), anti-κBJP (mix); (b), anti-ALκ (SIN); (c), anti-ALκ (KRA); (d), anti-ALλ (HEN). Amyloid deposits are shown by the diagonal arrows; blood is indicated by the vertical arrows.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.